![](/img/cover-not-exists.png)
A novel thromboxane receptor antagonist and synthase inhibitor, BM-573, reduces development and progression of atherosclerosis in LDL receptor deficient mice
Tillmann Cyrus, Yuemang Yao, Tao Ding, Jean Michel Dogné, Domenico PraticòVolume:
561
Year:
2007
Language:
english
Pages:
7
DOI:
10.1016/j.ejphar.2006.12.024
File:
PDF, 696 KB
english, 2007